Three of them demonstrated positive imaging findings indicative of transthyretin cardiac amyloidosis (ATTR-CA), meeting the 2020 AHA diagnostic criteria for cardiac amyloidosis with Grade 2–3 radiotracer uptake on visual grading. This evidence concerns the gene TTR and cardiac amyloidosis.